Arctic Bioscience
Less than 1K followers
ABS
Euronext Growth Oslo
Food & Beverage
Consumer Goods & Services
Overview
Investor consensus
Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical products and dietary supplements based on bioactive marine raw materials. The company is developing HRO350, a novel drug candidate for the treatment of patients with mild to moderate psoriasis. Dietary supplements are sold globally as both bulk ingredients and finished products under the ROMEGA brand, to both companies and private customers.
Read moreMarket cap
-
Turnover
-
Revenue
44.4M
EBIT %
-107.63 %
P/E
-
Dividend yield-%
-
All
Press releases
ShowingAll content types
Arctic Bioscience AS: Arctic Bioscience - Q3 2025 Operational update - Significant results on systemic inflammation
Arctic Bioscience AS: Arctic Bioscience - Invitation to presentation of Q3 operational update and HeROPA-analyses results
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools